- Home
- INHD vs NCEL Comparison
INHD vs NCEL Comparison
Compare INHD & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INHD | NCEL |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | Hong Kong | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 10.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | INHD | NCEL |
|---|---|---|
| Price | $1.41 | $2.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 806.6K | 194.7K |
| Earning Date | 02-13-2026 | 12-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,846,250.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.06 | $1.89 |
| 52 Week High | $474.72 | $7.64 |
Technical Indicators
Market Signals| Indicator | INHD | NCEL |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | N/A |
| Support Level | $1.29 | N/A |
| Resistance Level | $1.56 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 58.72 | 0.00 |
Price Performance
Historical ComparisonAbout INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About NCEL NewcelX Ltd. Ordinary Shares
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.